Labcorp to acquire BioReference Health assets from OPKO Health for $722M

Labcorp (LH) will acquire select assets of BioReference Health from OPKO Health (OPK) for $722 million in cash at closing, plus up to $150 million in an earnout based on 4Kscore Test revenue. The acquired business includes clinical and women's health testing, urology, corrections, and over 80 patient service centers. Labcorp expects the business to generate approximately $250 million in revenue in the first year after close.